These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 34881024)

  • 41. Cross-border injection drug use and HIV and hepatitis C virus seropositivity among people who inject drugs in San Diego, California.
    Horyniak D; Wagner KD; Armenta RF; Cuevas-Mota J; Hendrickson E; Garfein RS
    Int J Drug Policy; 2017 Sep; 47():9-17. PubMed ID: 28683432
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A Global Meta-analysis of the Prevalence of HIV, Hepatitis C Virus, and Hepatitis B Virus Among People Who Inject Drugs-Do Gender-Based Differences Vary by Country-Level Indicators?
    Leung J; Peacock A; Colledge S; Grebely J; Cunningham EB; Hickman M; Vickerman P; Stone J; Trickey A; Dumchev K; Lynskey M; Hines L; Griffiths P; Mattick RP; Degenhardt L; Larney S
    J Infect Dis; 2019 Jun; 220(1):78-90. PubMed ID: 30726973
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Systematic Review and Meta-Analysis of Global Prevalence of HBsAg and HIV and HCV Antibodies among People Who Inject Drugs and Female Sex Workers.
    Rashti R; Sharafi H; Alavian SM; Moradi Y; Mohamadi Bolbanabad A; Moradi G
    Pathogens; 2020 May; 9(6):. PubMed ID: 32486342
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Drug use and risk behaviour profile, and the prevalence of HIV, hepatitis C and hepatitis B among people with methamphetamine use in Iran.
    Moradi G; Hajarizadeh B; Rahmani K; Mohamadi-Bolbanabad A; Darvishi S; Zareie B; Zavareh FA; Sharafi H; Alavian SM; Ramazani R; Eftekhar M; Radfar SR; Piroozi B; Gouya MM
    Int J Drug Policy; 2019 Nov; 73():129-134. PubMed ID: 31654935
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Systematic Differences in HIV, Syphilis and Risk Behaviors among Street Based and Establishment Based Female Sex Workers in Kathmandu Valley of Nepal.
    Kakchapati S; Paudel T; Maharjan M; Lim A
    Nepal J Epidemiol; 2016 Dec; 6(4):620-630. PubMed ID: 28804674
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Baseline prevalence and correlates of HIV and HCV infection among people who inject drugs accessing a syringe services program; Miami, FL.
    Bartholomew TS; Onugha J; Bullock C; Scaramutti C; Patel H; Forrest DW; Feaster DJ; Tookes HE
    Harm Reduct J; 2020 Jun; 17(1):40. PubMed ID: 32522201
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevalence of HIV, viral hepatitis B/C and tuberculosis and treatment outcomes among people who use drugs: Results from the implementation of the first drop-in-center in Mozambique.
    Semá Baltazar C; Kellogg TA; Boothe M; Loarec A; de Abreu E; Condula M; Fazito E; Raymond HF; Temmerman M; Luchters S
    Int J Drug Policy; 2021 Apr; 90():103095. PubMed ID: 33429163
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevalence and correlates of HCV monoinfection and HIV and HCV coinfection among persons who inject drugs in Vietnam.
    Zhang L; Celentano DD; Le Minh N; Latkin CA; Mehta SH; Frangakis C; Ha TV; Mo TT; Sripaipan T; Davis WW; Quan VM; Go VF
    Eur J Gastroenterol Hepatol; 2015 May; 27(5):550-6. PubMed ID: 25769097
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sexual behaviours of men who inject drugs in northeast India.
    Kermode M; Armstrong G; Medhi GK; Humtsoe C; Langkham B; Mahanta J
    Harm Reduct J; 2015 Mar; 12():4. PubMed ID: 25889291
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Underreported injection drug use and its potential contribution to reported increase in sexual transmission of HIV in Kazakhstan and Kyrgyzstan.
    Deryabina AP; Patnaik P; El-Sadr WM
    Harm Reduct J; 2019 Jan; 16(1):1. PubMed ID: 30611251
    [TBL] [Abstract][Full Text] [Related]  

  • 51. HIV, hepatitis B, and hepatitis C prevalence and associated risk behaviors among female sex workers in three Afghan cities.
    Todd CS; Nasir A; Stanekzai MR; Bautista CT; Botros BA; Scott PT; Strathdee SA; Tjaden J
    AIDS; 2010 Jul; 24 Suppl 2(0 2):S69-75. PubMed ID: 20610952
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Injecting risk behaviours following treatment for hepatitis C virus infection among people who inject drugs: The Australian Trial in Acute Hepatitis C.
    Alavi M; Spelman T; Matthews GV; Haber PS; Day C; van Beek I; Walsh N; Yeung B; Bruneau J; Petoumenos K; Dolan K; Kaldor JM; Dore GJ; Hellard M; Grebely J;
    Int J Drug Policy; 2015 Oct; 26(10):976-83. PubMed ID: 26115881
    [TBL] [Abstract][Full Text] [Related]  

  • 53. HIV prevalence and risk among people who inject drugs in five South African cities.
    Scheibe A; Makapela D; Brown B; dos Santos M; Hariga F; Virk H; Bekker LG; Lyan O; Fee N; Molnar M; Bocai A; Eligh J; Lehtovuori R
    Int J Drug Policy; 2016 Apr; 30():107-15. PubMed ID: 26860326
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Behavioural Risk for HIV, Hepatitis B, and Hepatitis C Infections among a Population of Drug Users and Injectors across Four Regions in Ghana.
    Guure C; Obiri-Yeboah Laryea SM; Dery S; Baptista da Silva C; Asamoah-Adu C; Ayisi-Addo S; Loglo MG; Mohammed A; Torpey K
    Interdiscip Perspect Infect Dis; 2022; 2022():2544481. PubMed ID: 36092389
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sexual practices, sexual behavior and HIV risk profile of key populations in Nigeria.
    Ochonye B; Folayan MO; Fatusi AO; Bello BM; Ajidagba B; Emmanuel G; Umoh P; Yusuf A; Jaiyebo T
    BMC Public Health; 2019 Sep; 19(1):1210. PubMed ID: 31477063
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Correlates of sharing of needles and syringes among people who inject drugs in Dhaka city, Bangladesh.
    Hemel MM; Reza MM; Shafiq TK; Kabir MI; Rana AM; Khan SI
    J Infect Dev Ctries; 2021 Oct; 15(10):1497-1506. PubMed ID: 34780373
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effectiveness of pharmacy-based needle/syringe exchange programme for people who inject drugs: a systematic review and meta-analysis.
    Sawangjit R; Khan TM; Chaiyakunapruk N
    Addiction; 2017 Feb; 112(2):236-247. PubMed ID: 27566970
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A prospective cohort study of risk behaviours, retention and loss to follow-up over 5 years among women and men in a needle exchange program in Stockholm, Sweden.
    Karlsson N; Kåberg M; Berglund T; Hammarberg A; Widman L; Ekström AM
    Int J Drug Policy; 2021 Apr; 90():103059. PubMed ID: 33360734
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevalence of HIV, hepatitis B and hepatitis C and associated risk behaviours amongst injecting drug users in three Afghan cities.
    Nasir A; Todd CS; Stanekzai MR; Bautista CT; Botros BA; Scott PT; Strathdee SA; Tjaden J
    Int J Drug Policy; 2011 Mar; 22(2):145-52. PubMed ID: 21146392
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Seroprevalence survey of Egyptian tourism workers for hepatitis B virus, hepatitis C virus, human immunodeficiency virus, and Treponema pallidum infections: association of hepatitis C virus infections with specific regions of Egypt.
    el-Sayed NM; Gomatos PJ; Rodier GR; Wierzba TF; Darwish A; Khashaba S; Arthur RR
    Am J Trop Med Hyg; 1996 Aug; 55(2):179-84. PubMed ID: 8780457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.